beta-L-Fucp-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Term ID

CHEBI:146770

Synonyms

(2R,3S,4R,5S,6S)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
6-deoxy-beta-L-galacto-hexopyranosyl-(1->4)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose
6-deoxy-beta-L-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
beta-L-fucopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
Fuc(b1-4)Gal(b1-4)Glc
WURCS=2.0/3,3,2/[a2122h-1x_1-5][a2112h-1b_1-5][a1221m-1b_1-5]/1-2-3/a4-b1_b4-c1

Definition

A trisaccharide that is lactose in which the hydroxy group at the 4' position has been converted into the corresponding beta-L-fucopyranoseide.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-L-Fucp-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Phenotype where environments contain beta-L-Fucp-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Phenotype modified by environments containing beta-L-Fucp-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Human Disease Model